Oral Solid Dose Generics Portfolio

About Hikma

Hikma is a multinational pharmaceutical company with a mission to improve global access to high-quality medicines. In 2025, it achieved a significant milestone by becoming the largest pharmaceutical company in the MENA region by sales, underscoring the strength of its Branded division. Its strategy focuses on leveraging distinct competitive advantages across its three business segments—Injectables, Generics, and Branded—while investing in R&D, manufacturing, and leadership to drive consistent, profitable growth, particularly in optimizing its Injectables business.

Therapeutic Areas